Home Investment Portfolio DLVR Therapeutics Innovation Type: Therapeutics Cancer Type: Liver Funding Stage: Proof of Concept Fund: Compass Rose Novel nanoparticle delivery technology Related news There are currently no news items related to this portfolio company. [contact-form-7 id="0b0c7a8" title="General Contact"]